Kaufman Michael A's Form 4/A amendment
AmendedAgilysys Inc (AGYS) · filed Dec 15, 2023
- Accession no.
- 0001019056-23-000431
- Filed
- Dec 15, 2023, 5:59 PM ET
- Trade date
- Dec 6-8, 2023
- Filing delay
- 9 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Dec 8, 2023
This filing lists 3 non-derivative transactions. Open-market sales total $6.23M. It was filed 9 days after the trade.
This amendment replaces 0001019056-23-000413 (filed Dec 8, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kaufman Michael ACIK 0001426157 | Director, 10% Owner |
| Mak Capital One LLCCIK 0001385702 | 10% Owner |
| MAK Capital Fund LPCIK 0001426156 | 10% Owner |
| MAK Capital Distressed Debt Fund I, LPCIK 0001760572 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2023 | Common Stock | SSaleDisposed | −33,457 | $86.57 | −$2,896,228.62 | 3,565,320 | Indirect | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −28,473 | $84.24 | −$2,398,423.16 | 3,536,847 | Indirect | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −11,173 | $83.83 | −$936,576.73 | 3,525,674 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 Transaction Plan dated August 1, 2023 between MAK Capital One LLC ("MAK Capital") and BTIG, LLC.
- F2
MAK Capital acts as the investment manager of MAK Capital Fund LP ("MAK Fund") and MAK Capital Distressed Debt Fund I LP ("MAK CDD Fund). Michael A. Kaufman is the managing member of MAK Capital. Each of MAK Capital and Michael A. Kaufman ("Mr. Kaufman") may be deemed to indirectly beneficially own the shares of Common Stock held by MAK Fund and MAK CDD Fund. Each of MAK Capital and Mr. Kaufman disclaims such beneficial ownership, except to the extent of its pecuniary interest therein. Each of MAK Capital, MAK Fund, MAK CDD Fund and Mr. Kaufman may be deemed to be a member of a "group" (within the meaning of Rule 13d-5 under the Act) whose members in the aggregate beneficially own more than 10% of the outstanding shares of Common Stock.
- F3
27,736 shares were sold for MAK Fund and 5,721 shares were sold for MAK CDD.
- F4
23,604 shares were sold for MAK Fund and 4,869 shares were sold for MAK CDD.
- F5
9,262 shares were sold for MAK Fund and 1,911 shares were sold for MAK CDD.
Remarks
* The reported price is a weighted average price. The Reporting Persons undertake to provide to the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.